Another fantastic ARCS Australia Annual Conference this year!
A big thank you to ARCS Australia or once again delivering a highly successful conference filled with insightful conversations, valuable connections, and thought-provoking discussions across the life sciences sector. This year’s theme, “Life Sciences Unlocked: Shaping the Next Era,” lived up to expectations.
We thoroughly enjoyed attending and contributing to the event. Here’s a quick recap of Lucid Health Consulting’s involvement:
🔹 CEO Breakfast
Our Principal Consultant, George Papadopoulos, attended the CEO Breakfast, which Lucid Health Consulting was proud to sponsor as the inaugural breakfast sponsor in 2024. It was a great opportunity to connect with leaders from across the sector and discuss the opportunities and challenges shaping the future of life sciences.
🔹 From Functional Depth to Strategic Fluency: A Workshop for Medical Affairs & Life Sciences Professionals (Day 1)
George joined an outstanding panel of speakers including Faizz Fattah, Sharmia Bakar, Marina van der Merwe, Orin Chisholm, Joe Badolato, Bas Ebaid, and Nina Mapson Bone.
The workshop brought together professionals from Medical Affairs, Market Access, Regulatory Affairs, Clinical Development, and the broader life sciences ecosystem to explore a critical question:
How do we evolve from technical experts into strategic leaders who can influence, collaborate, and create meaningful impact across functions?
Through interactive discussions, live polling, and shared experiences, participants identified key capabilities they are looking to strengthen, including Strategic influence, Business acumen, AI fluency, public speaking and more.
One clear takeaway was that strategic capability development doesn’t develop by accident. It comes from actively seeking new perspectives, collaboration and continuously investing in personal and professional learning.
🔹 Chairing the “Navigating Pre-Registration Access: Ensuring Continuity of Supply Between Trial Completion and PBS Reimbursement” Workshop (Day 2)
George had the privilege of chairing this important discussion alongside panellists Matt Zeller, Con Konstantopoulos, and Krystal Barter, exploring the challenges and opportunities associated with ensuring patient access during the period between clinical trial completion and PBS reimbursement.
Proposed Solution Directions: What “Better” Could Look Like
- Platform-first approach (logistics and discoverability)
Create a platform that receives enrolment/order requests and routes supply through the most appropriate channel. Focus on improving systems and processes rather than rebuilding infrastructure or adding manual steps.
- Patient-centred program design and communication
Many patients are unaware that market access programs exist, with visibility and navigation often falling short. Over-reliance on clinicians as the primary access funnel creates a significant failure point given workload pressures and competing priorities. Patients and consumers should be involved earlier in designing practical access pathways (not just consultation).
- National alignment and cross-sector collaboration
The access gap must be recognised as a shared national challenge. Moving beyond siloed conversations toward pragmatic, cross-ecosystem problem-solving will be critical. While government has an important role, it must balance competing priorities across hospitals, prevention, aged care, innovation, and R&D.
- A pivotal window for action
There is a strong view that the next 12–24 months will be critical in shaping Australia’s access landscape and innovation competitiveness for the next 10–20 years.
🔹 Connecting at the Oncothera Booth
George also spent time with the team at Oncothera in the exhibition hall. As a member of the Oncothera Board of Directors, it was fantastic to see the level of engagement at the booth, with valuable discussions, new connections, and the exchange of ideas across industry, research, clinical practice, and patient advocacy.
Finally, congratulations to ARCS on its evolution to LifeSciences Australia. This exciting transition builds on decades of credibility and trust while better reflecting the organisation’s growing role across Australia’s life sciences sector.
We look forward to seeing how LifeSciences Australia continues to support and advance the industry in the years ahead. You can find out more here: LifeSciences Australia – About the Change
Thank you again to ARCS Australia for hosting such a valuable event. We are already looking forward to next year.
Recent Comments